Antitumor immune response of dendritic cells (DCs) expressing tumor-associated antigens derived from induced pluripotent stem cells: In comparison to bone marrow-derived DCs

International Journal of Cancer

Volumn 134, Issue 2, 2014, Pages 332-341

  Iwamoto, Hiromitsu ^a   Ojima, Toshiyasu ^a   Hayata, Keiji ^a   Katsuda, Masahiro ^a   Miyazawa, Motoki ^a   Iida, Takeshi ^a   Nakamura, Masaki ^a   Nakamori, Mikihito ^a   Iwahashi, Makoto ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

antitumor immune response; DCs vaccine therapy; genetically modified DCs; iPSDCs; TAA specific

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; CD86 ANTIGEN; CHROMIUM 51; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HGP 100 TUMOR ANTIGEN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME RELEASE; FEMALE; FLOW CYTOMETRY; LYMPH NODE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE TUMOR; VIRAL GENE DELIVERY SYSTEM;

ANTITUMOR IMMUNE RESPONSE; DCS VACCINE THERAPY; GENETICALLY MODIFIED DCS; IPSDCS; TAA-SPECIFIC;

ADENOVIRIDAE; ANIMALS; BONE MARROW; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; GP100 MELANOMA ANTIGEN; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84887467601     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28367     Document Type: Article

References (24)

1. Steinman RM,. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-96.
2. Steinman RM,. Decision about dendritic cells: past, present, and future. Annu Rev Immunol 2012; 30: 1-22.
3. Steinman RM,. Some active area of DC research and their medical potential. Eur J Immunol 2010; 40: 2085-130.
4. Matsuda K, Tsunoda T, Tanaka H, et al. Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells. Cancer Immunol Immunother 2004: 53; 609-16. (Pubitemid 38858334)
5. Nakamura M, Iwahashi M, Nakamori M, et al. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Clin Cancer Res 2002; 8: 2742-9. (Pubitemid 34856364)
6. Ojima T, Iwahashi M, Nakamura M, et al. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Int J Cancer 2006; 120: 585-93. (Pubitemid 44969030)
7. Ojima T, Iwahashi M, Nakamura M, et al. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Int J Oncol 2006; 28: 947-53.
8. Miyazawa M, Iwahashi M, Ojima T, et al. Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro. Cancer Lett 2011; 305: 32-9.
9. Poschke I, Mao Y, Adamson L, et al. Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunol Immunother 2012; 61: 827-38.
10. Tjomsland V, Spangeus A, Sandstrom P, et al. Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLos One 2010; 5: e13441.
11. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76. (Pubitemid 44233629)
12. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72. (Pubitemid 350138099)
13. Senju S, Haruta M, Matsunaga Y, et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 2009; 27: 1021-31.
14. Zhai Y, Yang JC, Spiess P, et al. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100. J Immunother 1997; 20: 15-25. (Pubitemid 28011520)
15. Okita K, Ichisaka T, Yamanaka S,. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-17. (Pubitemid 47080336)
16. Thomas KR, Capecchi MR,. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51: 503-12.
17. Kodama H, Nose M, Niida S, et al. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 1994; 22: 979-84. (Pubitemid 24292889)
18. Niwa H, Yamamura K, Miyazaki J,. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-9.
19. Lutz MB, Kukutsch N, Oglivie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223: 77-92. (Pubitemid 29096240)
20. Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126-31.
21. Takayama N, Nishimura S, Nakamura S, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010; 207: 2817-30.
22. Hayashi K, Ohta H, Kurimoto K, et al. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 2011; 146: 519-32.
23. Pérez-Díez A, Butterfield LH, Li L, et al. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene. Cancer Res 1998; 58: 5305-9. (Pubitemid 28551105)
24. Diebold SS, Cotten M, Koch N, et al. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther 2001; 8: 487-493. (Pubitemid 32266404)